Notably, our investigation revealed that the concurrent inhibition of RPA and autophagy heightened the radiosensitivity of NPC cells, suggesting a promising avenue to enhance therapeutic efficacy. This evidence concerns the gene RPA1 and nasopharyngeal carcinoma.